Bortezomib Fresenius Kabi
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Bortezomib Fresenius Kabi, covering 2025-02-13 to 2025-02-13. Get the full timeline:
Most recent: EMA Authorised: Bortezomib Fresenius Kabi (bortezomib) — Fresenius Kabi Deutschland GmbH